Clinical Trials in New Windsor, United States
Locations / New Windsor, United States
Delta Trials records 163 clinical trials conducted in New Windsor, United States, making it a notable site of clinical research activity. These trials across 130 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 13 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in New Windsor has changed over time.
163
Total Trials
130
Conditions
13
Terminated since 2020
Browse by condition (130 total)
- Diabetes mellitus, type 2 22 trialsAll Diabetes mellitus, type 2 trials
- Alzheimer's disease 15 trialsAll Alzheimer's disease trials
- Type 2 diabetes mellitus 11 trialsAll Type 2 diabetes mellitus trials
- Diabetes 11 trialsAll Diabetes trials
- All Chronic obstructive pulmonary disease trials
- Hypercholesterolemia 8 trialsAll Hypercholesterolemia trials
- All Agitation in patients with dementia of the alzheimer's type trials
- Asthma 5 trialsAll Asthma trials
- Cardiovascular disease 5 trialsAll Cardiovascular disease trials
- Type 2 diabetes 5 trialsAll Type 2 diabetes trials
- Dyslipidemia 4 trialsAll Dyslipidemia trials
- Colorectal cancer 4 trialsAll Colorectal cancer trials
- All Atherosclerotic cardiovascular disease trials
- Severe hypertriglyceridemia 4 trialsAll Severe hypertriglyceridemia trials
- Hypertension 4 trialsAll Hypertension trials
- Hypertriglyceridemia 4 trialsAll Hypertriglyceridemia trials
- Mild cognitive impairment 3 trialsAll Mild cognitive impairment trials
- Lyme disease 3 trialsAll Lyme disease trials
- Hyperlipidemia 3 trialsAll Hyperlipidemia trials
- Alzheimer's disease 3 trialsAll Alzheimer's disease trials